Ascendis Pharma A/S Announces Participation in 39th Annual J.P. Morgan Healthcare Conference

NEXT STORY
SUMITOVANT BIOPHARMA ANNOUNCES THE APPOINTMENT OF INDUSTRY VETERAN, DAVID MAREK, AS CHIEF EXECUTIVE OFFICER OF MYOVANT SCIENCES
PREV STORY
AzurRx BioPharma Announces Exclusive Worldwide License Agreement with First Wave Bio for Use of Proprietary Niclosamide Formulations to Treat Immune Checkpoint Inhibitor-Associated Colitis and COVID-19 Gastrointestinal Infections
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Antibiotics Market to Exceed $58,798.1 Million at a CAGR of 4.0% from 2020 to 2027 – Exclusive Report [234 Pages] By Research Dive

author_avatar
NASDAQ Market News

ALX Oncology Strengthens Immuno-Oncology Pipeline with Acquisition of ScalmiBio

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Oral Mucositis Market: Pharma Industry Attacks Severe Pain and Suffering Due to Cancer Treatments

BEVERLY, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News